World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
9432
World Ranking
4243
National Ranking
168

Ludo Lavreys publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ludo Lavreys sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 95 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ludo Lavreys D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ludo Lavreys sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ludo Lavreys is affiliated with Johnson & Johnson (Netherlands) in the Netherlands and has contributed extensively to the fields of medicine and immunology and microbiology. Their research primarily focuses on HIV research and treatment, with a notable emphasis on HIV/AIDS research and interventions, vaccines and immunoinformatics approaches, adolescent sexual and reproductive health, vaccine coverage and hesitancy, HIV/AIDS drug development and treatment, and hepatitis C virus research.

The scientist has published their work in several peer-reviewed venues, including:

  • EBioMedicine
  • The Lancet HIV
  • The Lancet Infectious Diseases
  • npj Vaccines
  • Microbiology Spectrum

Frequent co-authors collaborating with Ludo Lavreys include:

  • Maria Grazia Pau
  • Frank Tomaka
  • Daniel J Stieh
  • Janine van Duijn
  • Wouter Willems

Recent papers associated with Ludo Lavreys address various aspects of HIV vaccine research and immunology. These include:

  • Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial, 2024, The Lancet Infectious Diseases
  • Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22), 2020, The Lancet HIV
  • Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study, 2024, EBioMedicine
  • Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy, 2024, npj Vaccines
  • Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity, 2023, Microbiology Spectrum

The main fields of study for Ludo Lavreys are Medicine and Immunology and Microbiology, with subfields including Virology, Infectious Diseases, Molecular Biology, General Health Professions, and Health.

The scientist's body of work covers a broad spectrum of topics focused on infectious diseases and vaccine development, particularly pertaining to HIV and related interventions.

Best Publications

  • Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition

    Harold L. Martin;Barbra A. Richardson;Patrick M. Nyange;Ludo Lavreys

  • Infection with Trichomonas vaginalis Increases the Risk of HIV-1 Acquisition

    R. Scott McClelland;Laura Sangaré;Wisal M. Hassan;Ludo Lavreys;Ludo Lavreys

  • Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels

    Bhavna Chohan;Dorothy Lang;Manish Sagar;Bette Korber

  • HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 Loads

    Jared M Baeten;Bhavna Chohan;Ludo Lavreys;Ludo Lavreys;Vrasha Chohan

  • Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study

    Jared M. Baeten;Patrick M. Nyange;Barbra A. Richardson;Ludo Lavreys

  • Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis.

    Anthony M. Mills;Mark Nelson;Dushyantha Jayaweera;Kiat Ruxrungtham

  • Hormonal Contraception, Sexually Transmitted Diseases, and Risk of Heterosexual Transmission of Human Immunodeficiency Virus Type 1

    Harold L. Martin;Patrick M. Nyange;Barbra A. Richardson;Ludo Lavreys

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Gender differences in HIV-1 diversity at time of infection.

    Long Em;Martin Hl;Kreiss Jk;Rainwater Sm;Rainwater Sm

  • Effect of Circumcision on Incidence of Human Immunodeficiency Virus Type 1 and Other Sexually Transmitted Diseases: A Prospective Cohort Study of Trucking Company Employees in Kenya

    Ludo Lavreys;Joel P. Rakwar;Mary Lou Thompson;Denis J. Jackson

  • Higher Set Point Plasma Viral Load and More-Severe Acute HIV Type 1 (HIV-1) Illness Predict Mortality among High-Risk HIV-1–Infected African Women

    Ludo Lavreys;Ludo Lavreys;Jared M. Baeten;Varsha Chohan;R. Scott McClelland;R. Scott McClelland

  • Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.

    R S Mcclelland;C C Wang;K Mandaliya;J Overbaugh

  • HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus.

    E. Michelle Long;Stephanie M. J. Rainwater;Ludo Lavreys;Kishorchandra Mandaliya

  • Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.

    Jared M Baeten;Sarah Benki;Vrasha Chohan;Ludo Lavreys

  • Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study.

    R McClelland;Ludo Lavreys;Wisal Hassan;Kishorchandra Mandaliya

  • Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression

    Manish Sagar;Ludo Lavreys;Jared M. Baeten;Barbra A. Richardson;Barbra A. Richardson

  • Hormonal Contraception And Risk Of Hiv-1 Acquisition: Results Of A 10-year Prospective Study.

    Ludo Lavreys;Jared M Baeten;Harold L Martin;Julie Overbaugh

  • Contribution of HIV-1 Infection to Acquisition of Sexually Transmitted Disease: A 10-Year Prospective Study

    R. Scott McClelland;R. Scott McClelland;Ludo Lavreys;Ludo Lavreys;Christine Katingima;Julie Overbaugh

  • Evidence for Frequent Reinfection with Human Immunodeficiency Virus Type 1 of a Different Subtype

    Bhavna Chohan;Ludo Lavreys;Ludo Lavreys;Stephanie M. J. Rainwater;Julie Overbaugh

  • Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya.

    Joel Rakwar;Ludo Lavreys;Mary Lou Thompson;Denis Jackson

Frequent Co-Authors

Kishorchandra Mandaliya
Kishorchandra Mandaliya University of Washington
Barbra A. Richardson
Barbra A. Richardson University of Washington
Jeckoniah O. Ndinya-Achola
Jeckoniah O. Ndinya-Achola University of Nairobi
Jared M. Baeten
Jared M. Baeten University of Washington
Joan K. Kreiss
Joan K. Kreiss University of Washington
Julie Overbaugh
Julie Overbaugh Fred Hutchinson Cancer Research Center
R. Scott McClelland
R. Scott McClelland University of Washington
Job J. Bwayo
Job J. Bwayo University of Nairobi
Walter Jaoko
Walter Jaoko University of Nairobi
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but seeking flexible education options, exploring nursing and healthcare-related online degrees can be a practical step. Many students find programs like best online rn programs for non nurses particularly appealing, as they allow individuals without prior nursing experience to enter the field efficiently.

If you are looking to advance quickly in healthcare, accelerated nursing programs near me offer an excellent route. These programs are designed for students who already hold a degree in another discipline and want to earn their Bachelor of Science in Nursing (BSN) in a shorter timeframe.

For entry-level nursing roles, exploring easiest lpn programs to get into can help individuals begin gaining clinical experience and develop foundational patient care skills that complement immunology studies.

Finally, those interested in advanced practice can consider easiest nurse practitioner degree programs. These options prepare graduates for specialized roles within healthcare, often bridging the gap between scientific knowledge and patient care critical to immunological applications.

Best Scientists Citing Ludo Lavreys

Trending Scientists

Recently Published Articles